Taking people in GermanyPhase 1
Tests JADE201 in adults with rheumatoid arthritis
Tests a single dose of JADE201 in adults with rheumatoid arthritis.
Key facts
- Who runs it
- Jade Biosciences Inc.
- Where
- Berlin, GermanySee the siteAlso in 2 other countries, 3 sites
- Trial code
- Registry title
- Phase 1 Single Dose Study of JADE201 in Participants with Rheumatoid Arthritis
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 24 people, planned
- Started
- 5 Aug 2026
- Expected to end
- 24 Dec 2028
- Type of study
- Interventional
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rheumatoid arthritis to test a single dose of JADE201.
- Age
- 18 years or older
- Sex
- All sexes can join
Where in Germany
Also in 2 other countries, 3 sites
- Charite Research Organisation GmbHBerlin, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests JADE201 in adults with rheumatoid arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 5 October 2026